Tiziana Life Sciences (TILS) Sets New 52-Week Low at $91.00

Tiziana Life Sciences PLC (LON:TILS)’s share price reached a new 52-week low on Wednesday . The company traded as low as GBX 91 ($1.26) and last traded at GBX 95.50 ($1.32), with a volume of 33 shares trading hands. The stock had previously closed at GBX 95.50 ($1.32).

Separately, Beaufort Securities reiterated a “speculative buy” rating and set a GBX 400 ($5.53) price objective on shares of Tiziana Life Sciences in a research note on Tuesday, December 19th.

The firm has a market capitalization of $113.36 and a P/E ratio of -1,061.11.

TRADEMARK VIOLATION WARNING: This news story was published by Markets Daily and is owned by of Markets Daily. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://www.themarketsdaily.com/2018/03/14/tiziana-life-sciences-tils-sets-new-52-week-low-at-91-00.html.

Tiziana Life Sciences Company Profile

Tiziana Life Sciences PLC is a clinical-stage biotechnology company. The Company is focused on targeted drugs to treat diseases in oncology and immunology, with a focus on metastatic cancers. Its products in clinical stage include Milciclib and Foralumab. Its products in pre-clinical stage include TZLS-101 and TZLS-214.

Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply